Aspire expands oncology portfolio with prostate cancer hormone therapy
One man dies from prostate cancer every 45 minutes in the UK
Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise...
Record number of medicines face supply issues amidst spiralling VPAS rebate, warns BGMA
Rising generic medicine supply issues impact four out of five NHS prescriptions
The British Generic Manufacturers’ Association (BGMA) has renewed its criticism of the government's...
BGMA advocates ‘tailored’ approach to Statutory Scheme for branded medicines
The British Generic Manufacturers Association (BGMA) has backed the UK government's proposed changes to the Statutory Scheme for branded medicines, which includes a ‘Life...
Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform
The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...
BGMA calls for VPAS exemption for branded generics and biosimilars
The British Generic Medicines Association (BGMA) has called for exemption from the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), an agreement between...